Salute e Benessere

CLÉ DE PEAU BEAUTÉ ANNOUNCES SACHIKO NAKAJIMA AS RECIPIENT OF THE POWER OF…

The annual Power of Radiance Awards recognizes and celebrates women who are taking action by advocating for girls' education in their communities. The Awards were founded in 2019, and are based on Clé de Peau Beauté's belief that the key to a better world lies in unlocking the potential of girls especially through STEAM education. The annual Power of Radiance Awards recognizes and celebrates women who are taking action by advocating for girls' education in their communities. The Awards were...
PR Newswire
11/10/2024

Explore "Intensive Care Airway Clearance Technology" with BMC at ESICM 2024

Continuous exploration and exchange in clinical advancements with Leading Experts Continuous exploration and exchange in clinical advancements with Leading Experts For patients undergoing mechanical ventilation, the natural cough reflex is often suppressed due to reduced respiratory muscle function, leading to an increased risk of airway secretion accumulation. This can result in elevated respiratory resistance, inadequate ventilation, and potentially severe complications such as...
PR Newswire
11/10/2024

Immatics Announces Pricing of $150 Million Public Offering

Houston, Texas and Tuebingen, Germany, October 10, 2024– Immatics N.V. (NASDAQ: IMTX, “Immatics”), a clinical-stage biopharmaceutical company active in the discovery and development of T cell-redirecting cancer immunotherapies, announced today the pricing of its previously announced underwritten public offering of 16,250,000 ordinary shares at a public offering price of $9.25 per share. The gross proceeds from the offering, before deducting the underwriting discount and offering...
Nasdaq GlobeNewswire
11/10/2024

Global Pediatric Drugs Market is Predicted to Resister Growth at a CAGR of ~5%…

Key Takeaways from the Pediatric Drugs Market Report Key Takeaways from the Pediatric Drugs Market Report To read more about the latest highlights related to the pediatric drugs market, get a snapshot of the key highlights entailed in the Global Pediatric Drugs Market Report Pediatric Drugs Overview Pediatric drugs are medications specifically formulated and dosed for use in children, addressing the unique physiological and developmental needs of this population. Unlike adults,...
PR Newswire
10/10/2024

Metastatic Castration-Resistant Prostate Cancer Clinical Trial Pipeline Appears…

Key Takeaways from the Metastatic Castration-Resistant Prostate Cancer Pipeline Report Key Takeaways from the Metastatic Castration-Resistant Prostate Cancer Pipeline Report Request a sample and discover the recent advances in mCRPC treatment drugs @ Metastatic Castration-Resistant Prostate Cancer Pipeline Report The mCRPC pipeline report provides detailed profiles of pipeline assets, a comparative analysis of clinical and non-clinical stage mCRPC drugs, inactive and dormant assets,...
PR Newswire
10/10/2024

Procedure of the Annual General Meeting

ANNOUNCEMENT NO. 277 10 October 2024Procedure of the Annual General Meeting The Annual General Meeting of ChemoMetec A/S was held on 10 October 2024 at 5.30 p.m. at Nordsjællands KonferenceCenter.At the Annual General Meeting, the Board of Directors' report on the company's activities during the past year was presented, the annual report for 2023/24 was approved, and the Board of Directors and the Executive Board were granted discharge.The Annual General Meeting approved the...
Nasdaq GlobeNewswire
10/10/2024

EUROAPI completes the financing of its FOCUS-27 plan and moves forward with its…

Press Release €451M Revolving Credit Facility refinanced with a maturity extended to February 2029Issuance of a €200M Perpetual Deeply Subordinated Hybrid Bond subscribed by Sanofi€54M product capacity reservation for five products and further amendments to the global Manufacturing and Supply Agreement (MSA) agreed with Sanofi “The completion of the financing is an instrumental step in the execution of EUROAPI's strategic roadmap”said Ludwig de Mot, Chief...
Nasdaq GlobeNewswire
10/10/2024

Monthly information related to total number of voting rights and shares…

Listing market: Euronext Paris (Market segment C - ISIN Code: FR001400K4B1- Symbol: PHXM)Website : www.phaxiam.com DateTotal of shares composing the share capitalTotal of brut(1)voting rightsTotal of net(2)voting rights December 31, 20236 075 1056 226 9826 226 733January 31, 20246 075 1056 227 0026 226 753February 29, 20246 075 1056 226 9516 226 702March 29, 20246 075 1056 226 9386 226 689April 30, 2024...
Nasdaq GlobeNewswire
10/10/2024

Press release: Transparency Notification from Shareholders

Transparency Notification from ShareholdersGhent, Belgium – 10 October 2024 – Sequana Medical NV (Euronext Brussels: SEQUA)(the " Company " or " SequanaMedical "), a pioneer in the treatment of fluid overload in liver disease, heart failure and cancer, announces today that it received a transparency notification from the party listed below. Reason for notificationAggregate number of shares and voting rights held% of total outstanding shares(1)Sensinnovat BV...
Nasdaq GlobeNewswire
10/10/2024

Vitestro Welcomes Dave Hickey to Board of Directors as an Independent Board…

Dave Hickey brings over 20 years of leadership experience in the healthcare and medical technology sectors. In his most recent role at BD, he oversaw the development of cutting-edge diagnostic solutions and successfully scaled the business in the US and globally. Notably, he led BD's response during the COVID-19 pandemic, where he developed numerous rapid and molecular diagnostic tests in record time to support healthcare providers and patients worldwide. Prior to BD, Dave held various executive…
PR Newswire
10/10/2024

Pneumatic Tools Market Surges to USD 158.11 Billion by 2030, Propelled by 13.81%…

Download PDF Brochure: https://www.verifiedmarketreports.com/download-sample/?rid=46004 Download PDF Brochure:https://www.verifiedmarketreports.com/download-sample/?rid=46004 Browse in-depth TOC on Pneumatic Tools Market 202 - Pages 126 – Tables 37 – Figures Scope of The Report Global Pneumatic Tools Market Overview Rising Demand from Manufacturing and Automotive Industries The global pneumatic tools market benefits significantly from the expansion of...
PR Newswire
10/10/2024

Animal Antibacterial and Antibiotics Market Poised for Significant Growth…

Download PDF Brochure: https://www.marketresearchintellect.com/download-sample/?rid=211662 Download PDF Brochure: https://www.marketresearchintellect.com/download-sample/?rid=211662 202 – Pages 126 – Tables 37 – Figures Scope Of The Report Animal Antibacterial and Antibiotics Market Overview 1. Market Growth and Size The Animal Antibacterial and Antibiotics Market is experiencing notable growth, driven by the expanding livestock sector and increasing demand for...
PR Newswire
10/10/2024

Microfluidics Market to Hit USD 32.67 Billion by 2029 with 7.8% CAGR |…

Browse in-depth TOC on "Microfluidics Market" Browse in-depth TOC on "Microfluidics Market" 325 - Tables67 - Figures360 - Pages Microfluidics-based devices accounted for the largest share of the Microfluidics market. Based on the product segment, the Microfluidics market is segmented into – Microfluidics-based devices and microfluidic components. Advanced instruments that can regulate and analyse small volume of fluids are microfluidics-based devices. They accurately...
PR Newswire
10/10/2024

KeyBioscience Announces Extension of Strategic Collaboration with Lilly

This collaboration extends Lilly's rights to KeyBioscience's DACRA platform, including a new molecule that is anticipated to enter a Phase 2 study in people with obesity and osteoarthritis (OA) later this year. KeyBioscience will conduct and complete this study which is planning to enroll 600 people and have dual primary endpoints on body weight and alleviation of OA pain. This collaboration extends Lilly's rights to KeyBioscience's DACRA platform, including a new molecule that is anticipated...
PR Newswire
10/10/2024

ICCBBA Announces 2024 Enterprise Grant Awardees: Advancing Global Blood Safety

1. The Safe Blood for Africa FoundationAwardee:Prof. Claude Tayou Tagny, Country Project CoordinatorGrant Amount:$20,000Prof. Claude Tayou Tagny and the Safe Blood for Africa Foundation (SBFA) have been at the forefront of strengthening blood transfusion systems in over 20 countries across sub-Saharan Africa and Asia. With this grant, SBFA will further develop the blood service at the Yaoundé University Teaching Hospital (YUTH) in Cameroon by implementing a blood safety informatics system and…
PR Newswire
10/10/2024

Immatics Announces Proposed $150 Million Public Offering

Houston, Texas and Tuebingen, Germany, October 10, 2024– Immatics N.V. (NASDAQ: IMTX, “Immatics”), a clinical-stage biopharmaceutical company active in the discovery and development of T cell-redirecting cancer immunotherapies, announced today the commencement of an underwritten public offering of its ordinary shares. The offering is subject to market conditions and other factors, and there can be no assurance as to whether or when the offering may be completed, or as to the actual size...
Nasdaq GlobeNewswire
10/10/2024

Novo Holdings Launches Portfolio Company Booster Therapeutics to Advance New…

Harmful protein accumulation implicated in range of complex diseases also linked to proteasome dysfunction Harmful protein accumulation implicated in range of complex diseases also linked to proteasome dysfunction COPENHAGEN, Denmark , Oct. 10, 2024 /PRNewswire/ -- Novo Holdings, a leading global life sciences investor, today announced the launch of Booster Therapeutics (Booster / the Company), a biotechnology company developing a new class of proteasome activator medicines to treat...
PR Newswire
10/10/2024

Clario and PathAI Collaborate to Deliver Integrated Solution for GI Clinical…

This co-delivery model streamlines endoscopic and histopathology endpoints to improve efficiency in global GI studies. CROs and sponsors will benefit from an end-to-end process that covers training, logistics, tissue processing, slide digitization, image analysis, and data transfers all with the medical and scientific oversight of our experts. Sites will experience simplified workflows with improved training, reporting, and document management. This co-delivery model streamlines endoscopic…
PR Newswire
10/10/2024

Indivior Provides Preliminary Q3 2024 Results; Updates FY 2024 Guidance; Group…

RICHMOND, Va., Oct. 10, 2024 /PRNewswire/ -- Indivior PLC (Nasdaq/LSE: INDV) today announced preliminary Q3 2024 financial results and provided updated FY 2024 guidance. RICHMOND, Va. , Oct. 10, 2024 /PRNewswire/ -- Indivior PLC (Nasdaq/LSE: INDV) today announced preliminary Q3 2024 financial results and provided updated FY 2024 guidance. Comment byMark Crossley, CEO of Indivior PLC "We are seeing faster than expected initial adoption of the competitive product to SUBLOCADE...
PR Newswire
10/10/2024

Immatics Announces Updated Phase 1b Clinical Data on ACTengine® IMA203 TCR-T…

Company to hostconference call and webcasttoday, October 10, at 9:00 am EDT/3:00 pm CESTCompany announces updated Phase 1b clinical data on ACTengine® IMA203 targeting PRAME in 28 heavily pretreated metastatic melanoma patients with substantially enhanced maturity compared to the last data update in May 2024 and provides the first report on progression-free survival (PFS) and overall survival (OS)Based on the Phase 1b data, the Company will proceed directly to a...
Nasdaq GlobeNewswire
10/10/2024

Oncoinvent Announces First Patient Dosed in its Phase 2 Clinical Trial of…

The Phase 2 trial (NCT06504147) is a randomized controlled study assessing the efficacy and safety of Radspherin® in patients with peritoneal metastasis from ovarian cancer. The primary objective is to compare PFS between patients who receive Radspherin® after complete surgical resection following pre-operative chemotherapy, and patients who only undergo pre-operative chemotherapy and surgery. The study is being conducted at six centers in the US, UK, Norway, Spain and Belgium. Positive Phase…
PR Newswire
10/10/2024

European Medicines Agency Confirms Acceptance of Marketing Application for…

Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, announced today that the European Medicines Agency (EMA) has accepted a Marketing Authorization Application for AVT03, a proposed biosimilar candidate to Prolia® and Xgeva® (denosumab).“EMA acceptance marks an important step towards making AVT03 available to patients and caregivers in Europe,” said Joseph McClellan, Chief Scientific Officer of...
Nasdaq GlobeNewswire
10/10/2024

BVA Survey by IntyEssentials Reveals The Extent of Sexual Pain Among Women in…

The study highlights the frequency and severity of pain during intercourse in the female population in France. Almost 47% of women say they sometimes or often experience pain during penetrative sex, while 33% report pain after intercourse. Of those affected, 40% rate their pain as 6 or more on a scale of 1 to 10, underlining the severity of such pain. The study highlights the frequency and severity of pain during intercourse in the female population inFrance. Almost47% of women say they...
PR Newswire
10/10/2024

Implantica announces highly successful 2024 American Foregut Society meeting…

Implantica is actively working on the FDA approval process to bring RefluxStop® to the US market with the PMA filing of the second module (of three) expected in the near-term. The RefluxStop® procedure was at the forefront of the new innovation discussions at the AFS meeting. Implantica is actively working on the FDA approval process to bring RefluxStop® to the US market with the PMA filing of the second module (of three) expected in the near-term. The RefluxStop® procedure was at the…
PR Newswire
10/10/2024
Altri  Comunicati